Cancer Drug Current Events | Cancer Drug News | 3
|
| Page
3 of
140 |
2789 Results |
|
|
|
Sort By:
Page Views | Date |
Fighting cancer with aspirin?
When looking for new weapons in the war on cancer, scientists should turn to their medicine cabinets for an age-old remedy-aspirin. According to scientists at the University of Newcastle (UK), aspirin has cancer-fighting effects that extend beyond already understood Cox inhibitors. view more (2006-10-02)
Anti-psychotic drugs could help fight cancer
The observation that people taking medication for schizophrenia have lower cancer rates than other people has prompted new research revealing that anti-psychotic drugs could help treat some major cancers. view more (2009-08-12)
Experimental agent blocks prostate cancer in animal study
An experimental drug has blocked the progression of prostate cancer in an animal model with an aggressive form of the disease, new research shows. view more (2008-05-23)
Paradoxical protein might prevent cancer
One difficulty with fighting cancer cells is that they are similar in many respects to the body's stem cells. By focusing on the differences, researchers at Karolinska Institutet have found a new way of tackling colon cancer. The study is presented in the prestigious journal Cell. view more (2009-11-16)
Tablet is better all round for cancer patients
A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects - and a study of almost 2,000 patients has shown it is giving them a better chance of surviving the disease. view more (2007-10-09)
Drug shows promise against advanced form of lung cancer
Results of a multi-center clinical study of a drug currently approved for treatment of kidney cancer indicate that it may also be effective for people with recurrent and advanced lung cancer. view more (2006-06-05)
University of Kent Appoints Leading Cancer Researcher
One of the UKˇ¦s leading cancer researchers, Professor Bill Gullick, is to become the University of Kent at Canterburyˇ¦s (UKC) new Chair in Cancer Biology from 1 January 2000. Currently Principal Scientist at the Imperial Cancer Research Fund (ICRF) Molecular Oncology Unit in Hammersmith, and Professor of Molecular Oncology at the Imperial... view more... (1999-11-15)
New protein target may advance design of HIV and cancer drugs
Using small molecules containing platinum, Virginia Commonwealth University Massey Cancer Center researchers have created a process to inhibit a class of proteins important in HIV and cancer. view more (2006-05-31)
Discovery in worms by Queen's researchers points to more targeted cancer treatment
Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. view more (2009-11-11)
Drug therapy reduces neuroblastoma tumor growth in pre-clinical investigation
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have discovered a new drug combination that significantly hinders tumor growth in neuroblastoma, a childhood cancer. view more (2009-04-27)
UroGene and Pierre Fabre Médicament sign letter of intent
UroGene S.A. (Evry Génopole - France) and Pierre Fabre Médicament announced today the signature of a letter of intent for a three year collaboration to discover and develop new active compounds against a biological target identified by UroGene in advanced prostate cancer. This target is a cell surface protein which is elevated in... view more... (2002-01-28)
1 in 10 advanced colon cancer patients worry about prescription drug costs
The vast majority of advanced colon cancer patients in a clinical trial were not concerned about the cost of prescription drugs for managing chemotherapy side effects, such as infection, pain and nausea and few adopted strategies to reduce drug cost burdens after joining the clinical trial. view more (2009-06-01)
Dismissed leukemia drug helps cll patients, studies show
A drug once dismissed as ineffective in patients with chronic lymphocytic leukemia (CLL) has shown promising results in two phase I and II clinical trials, according to researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute. view more (2008-12-08)
Novel cancer drug reduces neuroblastoma growth by 75 percent
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found a new drug that restricts the growth of neuroblastoma, a childhood brain cancer. view more (2009-04-24)
Not Just for Depression Anymore
Prozac is regularly prescribed to ease the emotional pain of patients who are being treated for cancer. But can this common anti-depressant help to fight cancer itself? view more (2008-12-19)
New study finds advanced liver cancer patients live longer by taking anti-cancer drug sorafenib
Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug. view more (2008-07-24)
Metformin increases pathologic complete response rates in breast cancer patients with diabetes
Metformin, the common first-line drug for type 2 diabetes, may be effective in increasing pathologic complete response rates in diabetic women with early stage breast cancer who took the drug during chemotherapy prior to having surgery, paving the way for further research of the drug as a potential cancer therapy, according to researchers at The... view more... (2008-06-03)
Investigational cancer drug targets critical proteins
A drug under study to treat various cancers selectively kills cancer cells because of its affinity for a modified version of a critical heat shock protein they contain, researchers have found. view more (2007-04-16)
New device could cut chemotherapy deaths
A new method of delivering chemotherapy to cancer patients without incurring side effects such as hair loss and vomiting is being developed. view more (2006-03-31)
Study looks at new bladder cancer therapy for patients unresponsive to standard treatment
As many as half of patients with superficial bladder cancer do not respond to the standard first-line chemotherapy placed into the bladder, according to current multi-center outcomes data. When this happens, typically, their only option is surgical removal of the bladder. view more (2008-02-27)
|
|
| Page
3 of
140 |
2789 Results |
|
|
|
Sort By:
Page Views | Date |
|
